Skip to content
DataLookout
Menu

ProZ-UCNCT06642883

Evaluation of ProLife 10 FORTE on Gut Microbiota Composition in UC Patients

StatusUnknown
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
  2. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

Evaluation of the gut microbiota composition variation (microbiota test)
Timeframe: From enrollment to the end of treatment 8 weeks

Secondary (1)

Evaluation of gut microbiota pathways variation ( Picrust analysis)

Arms and interventions

Prolife 10 ForteActive comparator

Treatment: 1 dose/die (contains 10 ml with: in particular, 7 strains of Lactobacillus (L. casei R215, L. plantarum Lp-115, L. helveticus R0052, L. acidophilus La-14, L. gasseri Lg-36, L. brevis Lbr-35, L. rhamnosus HN001), 2 strains of Bifidobacteria (B. lactis Bl-04 and HN019) and Bacillus coagulans BC4. In addition, it contains 10 mg of glucoligosaccharide and a pool of Vitamin B (B1, B2, B6, B12).

PlaceboPlacebo comparator

Treatment 1dose/die ( All additional components except probiotics and vitamins)

Dietary supplements: Prolife, Placebo

Sites

1 site in 1 country

  • Edoardo Vincenzo SavarinoPadua, Padua, Italy